{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:31:18Z","timestamp":1779114678586,"version":"3.51.4"},"reference-count":0,"publisher":"Elsevier BV","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMP"],"published-print":{"date-parts":[[2025,3,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Hyperglycemia in patients with Diabetes Mellitus (DM) increases the risk of developing cardiomyopathy and heart failure. Elevation of\nsodium\/proton exchanger-1 (NHE-1) expression and activity in cardiomyocytes leads to greater sensitivity to neurohormonal stimulation and\ncardiomyopathy, whereas inhibition of Sodium-Glucose Cotransporter 2 (SGLT2) clinically benefits DM population in reducing heart failure risk<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Aims:<\/jats:title>\n<jats:p>This study characterized the expression profiles of NHE-1 and SGLT2 in H9c2 cardiomyoblasts under High Glucose (HG) exposure and examined\nthe effects of Empagliflozin (EMPA), an SGLT2 inhibitor, on the HG-induced cardiomyoblasts deterioration, in comparison with NHE-1 specific\ninhibitor cariporide and Rho\/ROCK inhibitor hydroxy fasudil.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Western blotting and immunofluorescent staining were used to monitor protein expression and subcellular location, respectively. Reactive Oxygen\nSpecies (ROS) production and mitochondrial membrane potential were measured by flow cytometry. Kinetic mitochondrial oxygen consumption\nrate and respiratory function were monitored by a real-time cell metabolic analyzer.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>HG treatment upregulated SGLT2 and NHE-1 expression and RhoA\/ROCK activity in H9c2 cardiomyoblasts. The HG-upregulated NHE-1 is\nlocalized in actin-rich cortical cytoplasm, implicating its involvement in cell shape and adhesion alterations. Treatment with NHE-1 and ROCK\ninhibitors, but not EMPA, significantly attenuated the HG-induced ROS overproduction and mitochondrial membrane potential elevation.\nHowever, EMPA treatment restored the HG-suppressed mitochondrial maximal respiration, spare respiratory capacity, and non-mitochondrial\noxygen consumption rate.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>In comparison, Rho\/ROCK and NHE-1 inhibitions effectively prevent ROS overproduction, while SGLT2 inhibition rescues the deteriorated\nmitochondrial respiratory function under diabetogenic conditions. Blockade of SGLT2, NHE-1, or Rho\/ROCK activity is useful for the prevention\nof diabetic cardiomyopathy.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0118761429360640250227054103","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:34:51Z","timestamp":1741066491000},"source":"Crossref","is-referenced-by-count":1,"title":["Empagliflozin Mitigates High Glucose-Disrupted Mitochondrial Respiratory\nFunction in H9c2 Cardiomyoblasts: A Comparative Study with NHE-1 and\nROCK Inhibition"],"prefix":"10.1016","volume":"17","author":[{"given":"Cheng-I","family":"Cheng","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang-Gung Memorial Hospital and Chang Gung University College of\nMedicine, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Huei","family":"Chou","sequence":"additional","affiliation":[{"name":"Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Taiwan"},{"name":"Center for General Education, Cheng-Shiu University, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Ling","family":"Shih","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang-Gung Memorial Hospital and Chang Gung University College of\nMedicine, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Han","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medical Research, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7803-9384","authenticated-orcid":true,"given":"Ying-Hsien","family":"Kao","sequence":"additional","affiliation":[{"name":"Department of Medical Research, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Current Molecular Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T22:56:42Z","timestamp":1746572202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/239946\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118761429360640250227054103","relation":{},"ISSN":["1874-4672"],"issn-type":[{"value":"1874-4672","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,3]]}}}